Meditation for subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials.

Researchers analyzed 25 studies involving over 2,000 older adults to determine whether meditation could help people experiencing memory problems, from early cognitive decline to Alzheimer's disease. The studies, published between 2013 and 2024, compared meditation practices to standard care or control groups. The researchers found that meditation significantly improved overall cognitive function, as measured by a standard mental status test. Participants who practiced meditation showed better memory and thinking abilities compared to those who didn't meditate. Additionally, meditation improved sleep quality and overall health status in these older adults. However, meditation did not significantly reduce symptoms of depression in this population. The type of meditation used varied across studies but generally involved simple, accessible techniques that could be practiced at home. These benefits suggest meditation could be a valuable, low-cost addition to standard treatment for older adults concerned about memory loss. Since meditation is non-invasive and carries minimal risk, it may be particularly appealing for patients looking for complementary approaches to support brain health. The researchers note that while results are promising, the studies had some limitations, including differences in meditation methods and small sample sizes. More high-quality research is needed to confirm these findings and determine the best meditation approaches for cognitive health. While this study focused on meditation rather than acupuncture, many integrative practitioners combine multiple approaches; patients interested in comprehensive care for cognitive health should seek qualified practitioners experienced in treating older adults.

This systematic review and meta-analysis evaluated 25 RCTs (n=2,095) examining meditation interventions for subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease. Primary outcome was global cognition assessed via Mini-Mental State Examination (MMSE); secondary outcomes included Pittsburgh Sleep Quality Index, SF-36, and Geriatric Depression Scale. Pooled analysis demonstrated statistically significant improvements in global cognitive performance (MD 2.22, 95% CI: 0.83-3.62, p=0.002), sleep quality (MD -1.40, 95% CI: -2.52 to -0.27, p=0.015), and health status (MD 3.50, 95% CI: 0.45-6.56, p=0.020). Depression outcomes showed no significant effect (SMD -0.16, 95% CI: -0.63 to 0.31, p=0.514). Clinical takeaway: Meditation represents a cost-effective, non-invasive adjunct therapy for cognitive and sleep improvements in older adults with cognitive decline. Clinicians should consider integrating meditation practices into comprehensive treatment protocols, though heterogeneity and limited sample sizes warrant cautious interpretation pending larger-scale trials.